Alongside proper antimicrobial treatment, albumin is administered at a dosage of 1.5 g/kg body weight at diagnosis, followed by 1 g/kg on day three, with the primary clinical benefit of AKI-HRS prevention and mortality reduction [40,45]. This evidence concerns the gene ALB and acute kidney injury.